ABCB1 and cancer: What is more, MG (1–50 μM) reduced the multidrug resistance of cancer cells to antitumor drugs through downregulating P-glycoprotein expression in a concentration- and time-dependent manner and increased the intracellular accumulation of calcein in NCI/ADR-RES cells (Han and Van Anh, 2012).